DOCSLIB.ORG

259 Subpart F—Immunological Test Systems

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
259 Subpart F—Immunological Test Systems Food and Drug Administration, HHS § 866.5065 subpart E of part 807 of this chapter used while measuring various kinds of, subject to the limitations in § 866.9. or parts of, protein molecules by var- ious immunochemical techniques, such [47 FR 50823, Nov. 9, 1982, as amended at 54 FR 25047, June 12, 1989; 66 FR 38792, July 25, as immunoelectrophoresis, immuno- 2001] diffusion, or chromatography. (b) Classification. Class I (general con- § 866.4800 Radial immunodiffusion trols). The device is exempt from the plate. premarket notification procedures in (a) Identification. A radial subpart E of part 807 of this chapter immunodiffusion plate for clinical use subject to the limitations in § 866.9. is a device that consists of a plastic [47 FR 50823, Nov. 9, 1982, as amended at 54 plate to which agar gel containing FR 25047, June 12, 1989; 66 FR 38792, July 25, antiserum is added. In radial 2001] immunodiffusion, antigens migrate through gel which originally contains Subpart F—Immunological Test specific antibodies. As the reagents Systems come in contact with each other, they combine to form a precipitate that is § 866.5040 Albumin immunological test trapped in the gel matrix and immo- system. bilized. (a) Identification. An albumin immun- (b) Classification. Class I (general con- ological test system is a device that trols). The device is exempt from the consists of the reagents used to meas- premarket notification procedures in ure by immunochemical techniques the subpart E of part 807 of this chapter albumin (a plasma protein) in serum subject to the limitations in § 866.9. and other body fluids. Measurement of [47 FR 50823, Nov. 9, 1982, as amended at 66 albumin aids in the diagnosis of kidney FR 38792, July 25, 2001] and intestinal diseases. (b) Classification. Class II (special § 866.4830 Rocket controls). The device is exempt from immunoelectrophoresis equipment. the premarket notification procedures (a) Identification. Rocket in subpart E of part 807 of this chapter immunoelectrophoresis equipment for subject to § 866.9. clinical use is a device used to perform [47 FR 50823, Nov. 9, 1982, as amended at 63 a specific test on proteins by using a FR 59227, Nov. 3, 1998] procedure called rocket immunoelectrophoresis. In this proce- § 866.5060 Prealbumin immunological dure, an electric current causes the test system. protein in solution to migrate through (a) Identification. A prealbumin agar gel containing specific antisera. immunological test system is a device The protein precipitates with the that consists of the reagents used to antisera in a rocket-shaped pattern, measure by immunochemical tech- giving the name to the device. The niques the prealbumin (a plasma pro- height of the peak (or the area under tein) in serum and other body fluids. the peak) is proportional to the con- Measurement of prealbumin levels in centration of the protein. serum may aid in the assessment of the (b) Classification. Class I (general con- patient’s nutritional status. trols). The device is exempt from the (b) Classification. Class I (general con- premarket notification procedures in trols). The device is exempt from the subpart E of part 807 of this chapter premarket notification procedures in subject to the limitations in § 866.9. subpart E of part 807 of this chapter [47 FR 50823, Nov. 9, 1982, as amended at 54 subject to § 866.9. FR 25047, June 12, 1989; 66 FR 38792, July 25, [47 FR 50823, Nov. 9, 1982, as amended at 65 2001] FR 2312, Jan. 14, 2000] § 866.4900 Support gel. § 866.5065 Human allotypic marker (a) Identification. A support gel for immunological test system. clinical use is a device that consists of (a) Identification. A human allotypic an agar or agarose preparation that is marker immunological test system is a 259 VerDate Apr<18>2002 06:36 Apr 28, 2002 Jkt 197069 PO 00000 Frm 00259 Fmt 8010 Sfmt 8010 Y:\SGML\197069T.XXX pfrm12 PsN: 197069T § 866.5080 21 CFR Ch. I (4–1–02 Edition) device that consists of the reagents stituents (molecules present in the nu- used to identify by immunochemical cleus of a cell, such as ribonucleic acid, techniques the inherited human pro- deoxyribonucleic acid, or nuclear pro- tein allotypic markers (such as nGm, teins). The measurements aid in the di- nA2 m, and Km allotypes) in serum and agnosis of systemic lupus other body fluids. The identification erythematosus (a multisystem auto- may be used while studying population immune disease in which antibodies at- genetics. tack the victim’s own tissues), hepa- (b) Classification. Class I (general con- titis (a liver disease), rheumatoid ar- trols). The device is exempt from the thritis, Sjogren’s syndrome (arthritis premarket notification procedures in subpart E of part 807 of this chapter with inflammation of the eye, eyelid, subject to § 866.9. and salivary glands), and systemic scle- rosis (chronic hardening and shrinking [47 FR 50823, Nov. 9, 1982, as amended at 65 of many body tissues). FR 2312, Jan. 14, 2000] (b) Classification. Class II (perform- § 866.5080 Alpha-1-antichymotrypsin ance standards). immunological test system. § 866.5110 Antiparietal antibody (a) Identification. An alpha-1- immunological test system. antichymotrypsin immunological test system is a device that consists of the (a) Identification. An antiparietal reagents used to measure by antibody immunological test system is immunochemical techniques alpha-1- a device that consists of the reagents antichymotrypsin (a protein) in serum, used to measure by immunochemical other body fluids, and tissues. Alpha-1- techniques the specific antibody for antichymotrypsin helps protect tissues gastric parietal cells in serum and against proteolytic (protein-splitting) other body fluids. Gastric parietal cells enzymes released during infection. are those cells located in the stomach (b) Classification. Class II (perform- that produce a protein that enables vi- ance standards). tamin B12 to be absorbed by the body. The measurements aid in the diagnosis § 866.5090 Antimitochondrial antibody immunological test system. of vitamin B12 deficiency (or pernicious anemia), atrophic gastritis (inflamma- (a) An Identification. tion of the stomach), and autoimmune antimitochondrial antibody immuno- connective tissue diseases (diseases re- logical test system is a device that sulting when the body produces anti- consists of the reagents used to meas- ure by immunochemical techniques the bodies against its own tissues). antimitochondrial antibodies in human (b) Classification. Class II (perform- serum. The measurements aid in the ance standards). diagnosis of diseases that produce a spectrum of autoantibodies (antibodies § 866.5120 Antismooth muscle antibody produced against the body’s own tis- immunological test system. sue), such as primary biliary cirrhosis (a) Identification. An antismooth mus- (degeneration of liver tissue) and cle antibody immunological test sys- chronic active hepatitis (inflammation tem is a device that consists of the re- of the liver). agents used to measure by (b) Classification. Class II (perform- immunochemical techniques the ance standards). antismooth muscle antibodies (anti- bodies to nonstriated, involuntary § 866.5100 Antinuclear antibody immunological test system. muscle) in serum. The measurements aid in the diagnosis of chronic hepa- (a) Identification. An antinuclear titis (inflammation of the liver) and antibody immunological test system is autoimmune connective tissue diseases a device that consists of the reagents (diseases resulting from antibodies pro- used to measure by immunochemical duced against the body’s own tissues). techniques the autoimmune antibodies in serum, other body fluids, and tissues (b) Classification Class II (perform- that react with cellular nuclear con- ance standards). 260 VerDate Apr<18>2002 06:36 Apr 28, 2002 Jkt 197069 PO 00000 Frm 00260 Fmt 8010 Sfmt 8010 Y:\SGML\197069T.XXX pfrm12 PsN: 197069T Food and Drug Administration, HHS § 866.5210 § 866.5130 Alpha-1-antitrypsin immun- beta globulins (serum protein) in serum ological test system. and other body fluids. Beta-globulin (a) Identification. An alpha-1- proteins include beta-lipoprotein, antitrypsin immunological test system transferrin, glycoproteins, and com- is a device that consists of the reagents plement, and are rarely associated with used to measure by immunochemical specific pathologic disorders. techniques the alpha-1-antitrypsin (a (b) Classification. Class I (general con- plasma protein) in serum, other body trols). The device is exempt from the fluids, and tissues. The measurements premarket notification procedures in aid in the diagnosis of several condi- subpart E of part 807 of this chapter tions including juvenile and adult cir- subject to § 866.9. rhosis of the liver. In addition, alpha-1- [47 FR 50823, Nov. 9, 1982, as amended at 65 antitrypsin deficiency has been associ- FR 2312, Jan. 14, 2000] ated with pulmonary emphysema. (b) Classification. Class II (perform- § 866.5170 Breast milk immunological ance standards). test system. (a) Identification. A breast milk § 866.5150 Bence-Jones proteins immunological test system is a device immunological test system. that consists of the reagents used to (a) Identification. A Bence-Jones pro- measure by immunochemical tech- teins immunological test system is a niques the breast milk proteins. device that consists of the reagents (b) Classification. Class I (general con- used to measure by immunochemical trols). The device is exempt from the techniques the Bence-Jones proteins in premarket notification procedures in urine and plasma. Immunoglobulin subpart E of part 807 of this chapter molecules normally consist of pairs of subject to the limitations in § 866.9. polypeptide chains (subunits) of un- equal size (light chains and heavy [47 FR 50823, Nov. 9, 1982, as amended at 59 chains) bound together by several di- FR 63007, Dec. 7, 1994; 66 FR 38793, July 25, sulfide bridges. In some cancerous con- 2001] ditions, there is a proliferation of one § 866.5200 Carbonic anhydrase B and plasma cell (antibody-producing cell) C immunological test system. with excess production of light chains of one specific kind (monoclonal light (a) Identification.
Load more

Recommended publications
  • Blood Coagulation and Haemostasis: a Review*
    BLOOD COAGULATION AND HAEMOSTASIS: A REVIEW* E. M. RODF_~QUE,M.D. AND J. E. WYNANDS, M.D., C.IVI.~ FnOM THE V~Y F_~aLY STUVmS of this subject, many controversies existed regard- ing the various factors and mechanisms involved in the dotting process. One simply has to review the current literature and note the complex, often variable terminology, and the differing opinions of several workers in this field to realize that many of the former controversies are still present. However, many facts have been firmly established. This review will deal primarily with these facts and will mention the disputed points only when they appear pertinent to a better under- standing of the problems of controlling haemorrhage. Various factors are involved in the haemostatic process; the established ones include (1) the extravascular tissues; (2) the vasculature itself, the size and type of vessel being important; (3) the number of functioning platelets, and (4) the plasma coagulation system,x,2 THE ErmAVASCtrLABTISSUES While the extravaseular tissues do not play a major role in the control of bleeding, yet "their integrity and/or the variations in the resistance they offer to escaping blood may determine the bleeding response of a particular part of the body after injury. The "black eye' is a well-known example."2 In other situations in which there is easy bruisability, as in the aged, in poor nutrition, in some women, and in disease states such as the Ehlers-Danlos syndrome, it is likely that poor extravascular support is a deciding or contributing factor. 2 THE V~CULATVBE Previous to the more advanced and tested knowledge of today, abnormal vascular function was implicated as the basic pathogenetic factor in a variety of bleeding disorders.
    [Show full text]
  • Patho-Physiology of Kallikrein System
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 10, No. 3 Copyright (£) 1980, Institute for Clinical Science, Inc. Patho-Physiology of Kallikrein System ROBERT W. COLMAN, M.D. Thrombosis Center and Hematology ¡Oncology, Section of the Department of Medicine, Temple University School of Medicine, Philadelphia, PA 19140 ABSTRACT The properties of the contact factors, factor XII, high molecular weight kininogen and prekallikrein are described as well as the abnormalities in the hereditary deficiencies of these proteins. The interactions of each of these proteins with the other as well as their regulation by plasma proteolytic inhibitors such as Cl inhibitor and antithrombin III are delineated. Biochemical techniques for measuring this system are discussed. Condi­ tions associated with abnormal synthesis of these proteins are described. Diseases in which increased kinin formation has been documented as well as disorders where there is strong evidence for the activation of kallikrein are presented. Further knowledge of this system should increase our under­ standing of its pathophysiological alterations. Introduction illustrates the various control mechanism possible in proteolysis, including activa­ The plasma proteolytic enzyme systems tion of inactive precursors, positive feed­ of coagulation, fibrinolysis and kinin for­ back, stochiometric inhibition, multistep mation have been categorized as a “tan­ amplification and enzymatic degradation gled web.” The three interlocking net­ of active products. works are linked together in two ways. Factor XII (a beta globulin), molecular First, the initiating pathways are common weight 90,000, is first converted to an ac­ and factor XII (Hageman) factor is a pro­ tive derivative of the same size, factor tein intimately involved in all.
    [Show full text]
  • Gamma Globulin”
    CLINICAL APPLICATION OF A SIMPLE METHOD FOR ESTIMATING “GAMMA GLOBULIN” B. V. Jager, Margaret Nickerson J Clin Invest. 1948;27(2):231-238. https://doi.org/10.1172/JCI101938. Research Article Find the latest version: https://jci.me/101938/pdf CLINICAL APPLICATION OF A SIMPLE METHOD FOR ESTIMATING "GAMMA GLOBULIN" 1 By B. V. JAGER AND MARGARET NICKERSON (From the Department of Medicine, School of Medicine, University of Utah, Salt Lake City) (Received for publication August 11, 1947) The electrophoretic technique offers the most cipitate is finely emulsified in 3.0 ml. of 33.3 per cent accurate method for serum fractionation. This saturated ammonium sulfate. The tube is recentrifuged for 30 minutes and the supernatant fluid is discarded. permits a quantitative separation of serum into The precipitate is dissolved in 10 ml. of saline and an albumin and into three major globulin fractions aliquot is employed to determine its protein content, using which are designated as alpha, beta and gamma a biuret method such as that of Weichselbaum (2). components. In recent years electrophoretic anal- Triplicate determinations may be made with an *yses of serum proteins have been performed by accuracy of + 2 per cent. Electrophoretic studies many investigators in a variety of diseases. The indicate that 73 to 83 per cent of this protein accumulated data from these studies have now at- fraction consists of gamma globulin, the remainder tained sufficient size and agreement that they may consisting of alpha and beta globulins. From 70 to be of value as an aid in the differential diagnosis 82 per cent of the total gamma globulin present of certain diseases or for following the course of in the serum is recovered in this fraction.
    [Show full text]
  • Raw Materials for R&D and Manufacturing
    Raw Materials for R&D and Manufacturing Native Proteins (human), Recombinant Proteins From Serum / Plasma or Manufactured in SF19, HEK293, e.coli Serum Free Freeze Protection, Serum Free Media Manufactured under cGMP upon request Sera Semipurified Antisera for Adsorption Purposes Control sera, Depleted Sera Origin: Human; bovine, ovine; goat, rabbit, donkey Assay and Cell Culture Supplements Growth Factors BSA Cohn V fraction: Origin Australia, USA, New Zealand; HSA in solution (25%) Trehalose ,Ectoins, Ready-to-Use Osmolytes Complete / Fragment Polyclonal Antibodies Ig E: human; Ig G goat, rat, rabbit, mouse, human cross-adsorbed antibodies, custom-manufactured, against chicken, human, mouse, rabbit, rat Ig A;G;M; conjugates horse radish peroxidase; fluorescence labels incl GFP analogs ARTIMMUN ANALYTIK GmbH Benzstrasse 6 D 65779 Kelkheim Tel 49-6195 674 724 Fax 49-6195-674 722 info at artimmun.eu Human Native Proteins (Bulk packing) Human Plasma Proteins Immunoglobulin M, Myeloma Albumin Immunoglobulin M, Fc5mu Fragment Alpha-1 Acid Glycoprotein Immunoglobulin M, mu Chain Alpha-1-Antichymotrypsin Kallikrein Alpha-1-Antitrypsin Kininogen, HMW Alpha-2-Antiplasmin Kininogen, LMW Alpha-2-HS-Glycoprotein Lipoprotein a, [Lp(a)] Alpha-2-Macroglobulin Lipoprotein, High Density Antithrombin III Lipoprotein, Intermediate Density Apolipoprotein AI Lipoprotein, Low Density Apolipoprotein AII Lipoprotein, Very Low Density Apolipoprotein B Plasmin Apolipoprotein CI Plasminogen Apolipoprotein CII Prealbumin Apolipoprotein CIII Apolipoprotein E Human
    [Show full text]
  • Cholesterol and Protein Studies in Early Stages of Traumatic Paraplegia and Tetraplegia
    CHOLESTEROL AND PROTEIN STUDIES IN EARLY STAGES OF TRAUMATIC PARAPLEGIA AND TETRAPLEGIA K. EDWARDS, FRANKEL, By B. B. SC., H. , M.B., B.S., M.R.C.P., and LUDWIG GUTTMANN, .E. SirNational Spinal Injuries Centre,C.B StokeM.D. Mandeville, F.R.C.P. ,Hospital, F.R.C.S. Aylesbury, England TRAUMATIC paraplegia and tetraplegia following fractures and fracture-dislocations of the vertebral column is inevitably associated in the first instance with primary shock, severe local damage and profound changes of the function of the autonomic mechanisms. As a result of this disaster, homeostasis is thrown into chaos, especially in transection or severe incomplete lesions of the cervical cord, and the regulatory function of the nervous system in maintaining a suitable internal environment in these high lesions is greatly reduced. Therefore it was thought worth while to study the behaviour of serum proteins and cholesterol in relation to some basic haematology in the immediate and early stages of traumatic para­ plegia and tetraplegia. Reports in the literature of similar comparative studies in acute traumatic lesions of the spinal cord are lacking but similar studies, including those of Woodford-Williams et al. (1962) have been performed in other types of afflictions. These authors examined the same variables in a series of elderly patients immediatelyafter cardiac or cerebral infarction, surgical operations, and congestive heart failure. Clinical Material. Twenty-six patients-21 male and 5 female-with spinal cord injuries as a result of vertebral fractures or fracture-dislocations were investigated, all of whom were admitted to the National Spinal Injuries Centre on or close to their date of injury.
    [Show full text]
  • Molecular Mechanisms of Relationship Between Blood Plasma Beta-Globulins and Protein Markers of Renal and Bladder Cancer
    BioNanoSci. (2015) 5:84–90 DOI 10.1007/s12668-015-0165-x Molecular Mechanisms of Relationship Between Blood Plasma Beta-globulins and Protein Markers of Renal and Bladder Cancer E. I. Erlykina & L. M. Obukhova & A. B. Yazykova & V. F. Rossokhin & T. N. Gorshkova & V. P. Frantsuzova Published online: 14 March 2015 # Springer Science+Business Media New York 2015 Abstract The aim of the investigation was to enhance the CD1b). Analysis of the relationship between individual blood screening diagnosis of epithelial tissue malignant tumors, the plasma β-globulin proteins and identified tissue markers molecular relationship between blood plasma protein fractions, showed the greatest number of protein-protein interactions for and carcinogenesis tissue markers in renal and bladder cancer. proteins with reduced level in malignant tumors: transferrin had Blood plasma of 87 cancer patients, not previously subjected to 11-interactor proteins, as well as angiostatin had only 4. The antitumor treatment, and 9 patients with psoriasis was studied. involvement of protein markers interacting with individual pro- Blood plasma of 52 healthy people was used as control. Bio- teins of blood plasma β-globulin fractions in the signaling path- chemical parameters were evaluated on the analyzer BKoneLab ways that regulate apoptosis and cell proliferation was shown. 20 / 20i^ (Finland). Statistical analysis was performed using the Changes in the content of β-globulins of blood plasma in ma- software Statistica 6.0. Network construction of protein-protein lignant tumors of epithelial tissues, including renal and epithe- interactions was performed by means of Cytoscape software, lial cancer are suggested to be considered as specific pathogenic using databases STRING, BioGrid, SwissPro.
    [Show full text]
  • Immunofluorescent Studies in Adult Celiac Disease
    Immunofluorescent Studies in Adult Celiac Disease Walter Rubin, … , Marvin H. Sleisenger, Graham H. Jeffries J Clin Invest. 1965;44(3):475-485. https://doi.org/10.1172/JCI105161. Research Article Find the latest version: https://jci.me/105161/pdf Journal of Clinical Investigation Vol. 44, No. 3, 1965 Immunofluorescent Studies in Adult Celiac Disease * WALTER RUBIN,t ANTHONY STEPHEN FAUCI, MARVIN H. SLEISENGER, AND GRAHAM H. JEFFRIES t WITH THE TECHNICAL ASSISTANCE OF SUE MARGOLIS (From the Department of Medicine, Cornell University Medical College, New York, N. Y.) The etiology of childhood and adult celiac dis- Two hypotheses of the mechanism of gluten ease is not known. It has been established, how- toxicity in celiac patients have been proposed ever, that gluten, a complex heterogeneous pro- (3). One hypothesis is that celiac disease is the tein in wheat and other cereal grains, plays a sig- result of an inborn error of metabolism-a defi- nificant role in the pathogenesis of the disease, and ciency of a specific peptidase in the intestinal mu- that the harmful factor resides in gliadin, the al- cosa, which results in the accumulation of indi- cohol soluble fraction of gluten (1-4). Treatment gestible toxic peptides of gliadin. Two recent of celiac disease with a gluten-free diet results in observations, however, have failed to demonstrate clinical and biochemical improvement usually ac- a specific peptidase deficiency in the small intes- companied by a decrease in the severity of the tinal mucosa of celiac patients (10, 11). pathologic lesion in the proximal small intestinal The second hypothesis suggests that celiac dis- mucosa.
    [Show full text]
  • The Electrophoretic Analyses of the Serum Proteins in Diseases of the Liver
    THE ELECTROPHORETIC ANALYSES OF THE SERUM PROTEINS IN DISEASES OF THE LIVER Seymour J. Gray, E. S. Guzman Barron J Clin Invest. 1943;22(2):191-200. https://doi.org/10.1172/JCI101382. Research Article Find the latest version: https://jci.me/101382/pdf THE ELECTROPHORETIC ANALYSES OF THE SERUM PROTEINS IN DISEASES OF THE LIVER By SEYMOUR J. GRAY AND E. S. GUZMAN BARRON (From the Chemical Division of the Department of Medicine, University of Chicago, Chicago) (Received for publication September 4, 1942) The intimate association of the liver with the compared. Patients with varying degrees of liver maintenance of normal serum proteins is well insufficiency were studied in each group. established. An increase in serum globulin, with inversion of the albumin-globulin ratio, is a com- METHOD mon finding in cirrhosis of the liver, but normal The blood samples were obtained from the patients serum proteins are observed frequently in the before breakfast. The serum was diluted with 3 parts of veronal buffer made by mixture of the required amounts acute parenchymatous diseases of the liver like of 0.025 M veronal, 0.025 M HCI, and 0.025 M NaCl to catarrhal jaundice and arsenical hepatitis (1). a pH value of 7.8 at 250 C., and dialyzed against several The serum protein fractions in cancer of the liver liters of this buffer for 3 to 4 days, at 30 C., the buffer are quite variable. being changed daily. The protein solution was then Determination of the serum proteins by the centrifuged at 30 C. before being introduced into the electrophoresis cell.
    [Show full text]
  • S .' 30/3 7 CONTRACEPTION
    S / 30 / s .' 30/3 7 CONTRACEPTION EFFECTS OF ORAL CONTRACEPTION ON LIVER FUNCTION TESTS AND SERUM PROTEINS IN WOMEN WITH PAST VIRAL HEPATITIS M.M. Shaaban*, W.A. Hammad, M.F. Fathalla, S.A. Ghaneimah, M.M. El-Sharkawy T.H. Salim, M.Y. Ali, W.C. Liao** and S.C. Smith** Assiut University, Departments of Obstetrics and Gynecology, Biochemistry and Tropical Medicine, P. 0. Box 30, Assiut, Egypt and ** International Fertility Research Program, Research Triangle Park, North Carolina, U. S. A. ABSTRACT Forty-three women who had had viral hepatitis one or more years ago and 35 healthy women who were age and parity matched were given an oral contraceptive containing 0.05ig ethinyl estradiol and 0.5mg levonorgestrel for six consecutive months. Liver function tests (serum bilirubin, SGOT, SGPT aid serum alkaline phosphatase) and serum proteins (total, albumin, globulins, ceruloplasmin, haptoglobin and alpha-1 antitrypsin) were measured before beginning trkeatment and after three and six months of use. Past hepatitis won!n experienced increased unconjugated bilirubin, SGOT, SGPT and alkaline phosphatase levels throughout the six months while the control women showed less pronounced changes during the first three months with tendency to reversion to normal during the subsequent three months; the group X time of test interactions were significant­ ly different between the two groups. Serum haptoglobin decreased significantly in both groups but the past-hepatitis group showed a more persistent change with time. Changes also occurred in serum albumin, alpha-1 and beta globulins, cerulo­ plasmin but without group effect or group X time interactions. * To whom correspondence should be adressed.
    [Show full text]
  • International Standardization of Bed Rest Standard Measures
    International Standardization of Bed Rest Standard Measures Ronita L. Cromwell, PhD Flight Analogs Project Scientist Standardization of Bed Rest Studies ► International Multidisciplinary Artificial Gravity (IMAG) project (2005) ► Standardization of AG studies ► Screening ► Standard conditions ► Data management ---------------------------------------------------------------------------------------------------------------------------- ► 2 Standardization of Bed Rest Studies ► International Countermeasures Working Group (ICMWG) ► International Academy of Astronautics Study Group ► International Standards for Bed Rest Studies q Co-Chairs: Patrik Sunblad (ESA) and Oleg Orlov (IBMP) q Secretary: Dave Francisco (NASA) q Overall Goal: To define and agree internationally, on standard conditions and basic, standard measurements for spaceflight related bed rest studies. q Standard Conditions Assessment –Oliver Angerer (ESA) q Meeting February 1-2, 20 1 0 at USRA q Standard Measures Assessment – Ronita Cromwell (NASA) q Patrik Sunblad (ESA), Irina Larina (IBMP) ---------------------------------------------------------------------------------------------------------------------------- 0 3 Standard............... .............................................................................................................................. Measures Assessment ► Identified discipline experts from each agency (NASA, ESA, IBMP) to assess the standard measures. Cardiovascular Richard Hughson Steve Platts Olga Vinogradova Muscle Joern Rittweger Lori Ploutz-Snyder
    [Show full text]
  • Grass Pollens • Almond Is the Edible Seed of a Drupe in This Series
    Legumes, Nuts & Seeds Allergy – Which allergens? Author: Dr Harris Steinman, Allergy Resources International, P O Box 565, Milnerton 7435, South Africa, [email protected]. All rights reserved. No part of this publication may be reproduced in any form without the written consent of Phadia AB. ©Phadia AB, 2008 Design: RAK Design AB, 2008 Printed by: X-O Graf Tryckeri AB, Uppsala, Sweden ISBN 91-970475-5-4 Contents Introduction ............................................................................. 5 f20 Almond (Amygdalus communis) ..................................... 9 f6 Barley (Hordeum vulgare) ............................................ 15 f310 Blue vetch (Lathyrus sativus) ....................................... 22 f18 Brazil nut (Bertholletia excelsa) ................................... 26 f11 Buckwheat (Fagopyrum esculentum) ............................ 32 f202 Cashew nut (Anacardium occidentale) .......................... 41 f309 Chick pea (Cicer arietinus) .......................................... 49 f36 Coconut (Cocos nucifera) ............................................. 54 f55 Common millet (Panicum milliaceum) .......................... 59 f305 Fenugreek (Trigonella foenum-graecum) ........................ 64 f56 Foxtail millet (Setaria italica) ....................................... 67 f79 Gluten (from Triticum aestivum) ................................... 70 f315 Green bean (Phaseolus vulgaris) ................................... 77 f17 Hazel nut (Corylus avellana) .......................................
    [Show full text]
  • Identification and Characterisation of Food Allergens
    P1: SFK/UKS P2: SFK c03 BLBK189-Coutts June 23, 2009 13:54 Printer Name: Yet to Come 3 Identification and characterisation of food allergens E. N. Clare Mills, Philip Johnson, Yuri Alexeev, and Heimo Breiteneder 3.1 INTRODUCTION As part of its normal humoral immune responses, in a process generally known as sensiti- sation, the body produces various different types of molecules called immunoglobulins (Igs or antibodies) which are designated as IgA, IgG, IgM and IgE. These molecules comprise a binding domain which is capable of recognising, usually with high affinity and speci- ficity, ‘non-self’ molecules which include those found in microbes, parasites, environmental agents such as pollen and dust, as well as dietary proteins. In one type of allergic disease known as type I hypersensitivity, the repertoire of antibodies is altered, the body produc- ing larger quantities of IgE, the antibody class normally produced in response to parasitic infections. These IgE responses are directed towards a variety of environmental agents, the target molecules recognised by IgE being termed allergens. It is these molecules that are responsible for triggering an allergic reaction, a process also known as elicitation. IgE works by becoming associated with cells, such as mast cells, which are packed full of inflammatory mediators like histamine. On binding multivalent allergen, the surface bound IgE becomes ‘cross-linked’, triggering release of the mediators, such as histamine, which actually cause the symptoms associated with allergic reactions. Allergens are usually proteinaceous in nature, the sites recognised by the IgE being known as epitopes. These epitopes can comprise either linear sequences of amino acids (also termed continuous) or disparate portions of a protein’s amino acid sequence which are brought together by the folding of the polypeptide chain to form a discontinuous, or conformational, epitope.
    [Show full text]